CN1046720C - 用二环中间体的核苷类似物立体选择合成 - Google Patents
用二环中间体的核苷类似物立体选择合成 Download PDFInfo
- Publication number
- CN1046720C CN1046720C CN94190356A CN94190356A CN1046720C CN 1046720 C CN1046720 C CN 1046720C CN 94190356 A CN94190356 A CN 94190356A CN 94190356 A CN94190356 A CN 94190356A CN 1046720 C CN1046720 C CN 1046720C
- Authority
- CN
- China
- Prior art keywords
- formula
- halogen
- compound
- methyl
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (21)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9311709.1 | 1993-06-07 | ||
GB939311709A GB9311709D0 (en) | 1993-06-07 | 1993-06-07 | Stereoselective synthesis of nucleoside analogues using bicycle intermediate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1110479A CN1110479A (zh) | 1995-10-18 |
CN1046720C true CN1046720C (zh) | 1999-11-24 |
Family
ID=10736757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94190356A Expired - Fee Related CN1046720C (zh) | 1993-06-07 | 1994-06-07 | 用二环中间体的核苷类似物立体选择合成 |
Country Status (22)
Country | Link |
---|---|
US (1) | US5763606A (zh) |
EP (1) | EP0654031B1 (zh) |
JP (1) | JP3110461B2 (zh) |
KR (1) | KR100304072B1 (zh) |
CN (1) | CN1046720C (zh) |
AT (1) | ATE188215T1 (zh) |
AU (1) | AU668829B2 (zh) |
BR (1) | BR9405423A (zh) |
CA (1) | CA2141029C (zh) |
DE (1) | DE69422374T2 (zh) |
DK (1) | DK0654031T3 (zh) |
ES (1) | ES2139744T3 (zh) |
FI (1) | FI112078B (zh) |
GB (1) | GB9311709D0 (zh) |
HK (1) | HK1008673A1 (zh) |
HU (1) | HU219199B (zh) |
NO (1) | NO303449B1 (zh) |
NZ (1) | NZ267379A (zh) |
OA (1) | OA10349A (zh) |
PL (1) | PL180870B1 (zh) |
RU (1) | RU2139870C1 (zh) |
WO (1) | WO1994029301A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5684164A (en) * | 1988-04-11 | 1997-11-04 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
WO1996012716A1 (en) * | 1994-10-22 | 1996-05-02 | Chong Kun Dang Corp. | Nucleoside derivatives and process for preparing thereof |
JP4249393B2 (ja) | 1998-08-12 | 2009-04-02 | トライアングル・ファーマシューティカルズ,インコーポレイテッド | 1,3−オキサチオランヌクレオチドの製造方法 |
US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
CA2308559C (en) | 2000-05-16 | 2005-07-26 | Brantford Chemicals Inc. | 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues |
CN102911166B (zh) * | 2001-03-01 | 2016-08-17 | 基利得科学公司 | 顺-ftc的多晶型物及其它晶型 |
ES2308136T3 (es) * | 2003-01-14 | 2008-12-01 | Gilead Sciences, Inc. | Composiciones y procedimientos para la politerapia antiviral. |
WO2005074654A2 (en) * | 2004-02-03 | 2005-08-18 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010496A1 (en) * | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
WO1993003027A1 (en) * | 1991-08-01 | 1993-02-18 | Biochem Pharma Inc. | 1,3-oxathiolane nucleoside analogues |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
US5332814A (en) * | 1991-11-12 | 1994-07-26 | Ciba-Geigy Corporation | Process for the preparation of carbacyclic nucleosides, and intermediates |
-
1993
- 1993-06-07 GB GB939311709A patent/GB9311709D0/en active Pending
- 1993-11-19 OA OA60438A patent/OA10349A/en unknown
-
1994
- 1994-06-07 NZ NZ267379A patent/NZ267379A/en not_active IP Right Cessation
- 1994-06-07 KR KR1019950700453A patent/KR100304072B1/ko not_active IP Right Cessation
- 1994-06-07 AU AU69667/94A patent/AU668829B2/en not_active Ceased
- 1994-06-07 EP EP94918252A patent/EP0654031B1/en not_active Expired - Lifetime
- 1994-06-07 US US08/379,644 patent/US5763606A/en not_active Expired - Fee Related
- 1994-06-07 CA CA002141029A patent/CA2141029C/en not_active Expired - Fee Related
- 1994-06-07 RU RU95108553A patent/RU2139870C1/ru not_active IP Right Cessation
- 1994-06-07 DK DK94918252T patent/DK0654031T3/da active
- 1994-06-07 AT AT94918252T patent/ATE188215T1/de not_active IP Right Cessation
- 1994-06-07 DE DE69422374T patent/DE69422374T2/de not_active Expired - Fee Related
- 1994-06-07 CN CN94190356A patent/CN1046720C/zh not_active Expired - Fee Related
- 1994-06-07 PL PL94307350A patent/PL180870B1/pl not_active IP Right Cessation
- 1994-06-07 HU HU9500364A patent/HU219199B/hu not_active IP Right Cessation
- 1994-06-07 BR BR9405423A patent/BR9405423A/pt not_active Application Discontinuation
- 1994-06-07 JP JP07501139A patent/JP3110461B2/ja not_active Expired - Fee Related
- 1994-06-07 WO PCT/CA1994/000311 patent/WO1994029301A1/en active IP Right Grant
- 1994-06-07 ES ES94918252T patent/ES2139744T3/es not_active Expired - Lifetime
-
1995
- 1995-02-06 NO NO950432A patent/NO303449B1/no unknown
- 1995-02-07 FI FI950535A patent/FI112078B/fi active
-
1998
- 1998-07-02 HK HK98108821A patent/HK1008673A1/xx not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010496A1 (en) * | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
WO1993003027A1 (en) * | 1991-08-01 | 1993-02-18 | Biochem Pharma Inc. | 1,3-oxathiolane nucleoside analogues |
Also Published As
Publication number | Publication date |
---|---|
ES2139744T3 (es) | 2000-02-16 |
CN1110479A (zh) | 1995-10-18 |
EP0654031A1 (en) | 1995-05-24 |
KR100304072B1 (ko) | 2001-11-22 |
HU219199B (en) | 2001-03-28 |
JPH08505643A (ja) | 1996-06-18 |
HU9500364D0 (en) | 1995-05-29 |
DE69422374T2 (de) | 2000-06-29 |
OA10349A (en) | 2001-10-18 |
BR9405423A (pt) | 1999-05-25 |
PL180870B1 (pl) | 2001-04-30 |
HK1008673A1 (en) | 1999-05-14 |
RU95108553A (ru) | 1996-11-20 |
NO950432D0 (no) | 1995-02-06 |
DE69422374D1 (de) | 2000-02-03 |
ATE188215T1 (de) | 2000-01-15 |
HUT73630A (en) | 1996-08-28 |
AU668829B2 (en) | 1996-05-16 |
DK0654031T3 (da) | 2000-06-13 |
US5763606A (en) | 1998-06-09 |
GB9311709D0 (en) | 1993-07-21 |
FI112078B (fi) | 2003-10-31 |
CA2141029A1 (en) | 1994-12-22 |
NO303449B1 (no) | 1998-07-13 |
WO1994029301A1 (en) | 1994-12-22 |
FI950535A (fi) | 1995-02-07 |
NZ267379A (en) | 1997-04-24 |
CA2141029C (en) | 2000-07-25 |
EP0654031B1 (en) | 1999-12-29 |
RU2139870C1 (ru) | 1999-10-20 |
NO950432L (no) | 1995-03-13 |
AU6966794A (en) | 1995-01-03 |
PL307350A1 (en) | 1995-05-15 |
JP3110461B2 (ja) | 2000-11-20 |
FI950535A0 (fi) | 1995-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1151146C (zh) | 核苷类似物的非对映选择合成方法 | |
CN1035555C (zh) | 非对映选择性合成核苷的方法 | |
CN1046720C (zh) | 用二环中间体的核苷类似物立体选择合成 | |
JPH08504212A (ja) | 抗ウイルス特性を有する置換1,3‐オキサチオランを調製する方法 | |
US20030060476A1 (en) | Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration | |
AU713764B2 (en) | Processes for high-yield diastereoselective synthesis of dideoxynucleosides | |
FI102279B (fi) | Välituotteita nukleosidien diastereoselektiivisiin synteesimenetelmiin | |
CN1222157A (zh) | 高收率非对映选择性合成二脱氧核苷的方法 | |
CA2188306C (en) | Process for the diastereoselective synthesis of nucleoside analogues | |
CN1064484A (zh) | 新的四氢呋喃中间体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHIRE BIOCHEM INC Free format text: FORMER NAME OR ADDRESS: BIOCHEM PHARMA INC. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Quebec Patentee after: Biochem Pharma Inc. Address before: Quebec Patentee before: Biochem Pharma Inc. |
|
C56 | Change in the name or address of the patentee |
Owner name: CHARLES CANADIAN CO., LTD. Free format text: FORMER NAME OR ADDRESS: SHIRE BIOCHEM INC |
|
CP01 | Change in the name or title of a patent holder |
Address after: Quebec Patentee after: Charles Canada Company Address before: Quebec Patentee before: Biochem Pharma Inc. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 19991124 |